Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...

In an exciting scientific first, researchers at the Allen Institute successfully designed a new gene therapy that reversed ...

Drugmaker uniQure reported the results of its small but “groundbreaking” Phase I/II study this week, finding that a high dose of its AMT-130 therapy slowed disease progression by 75% after 36 months.

Researchers have long believed that neurons rely on glucose nearly entirely for fuel. The brain’s enormous energy ...

A high-fat, low-carb ketogenic diet may protect the brain from early Alzheimer’s disease changes in people genetically at ...

Scientists have directly visualised alpha-synuclein oligomers in human brain tissue, a key trigger in Parkinson's disease ...

Doctors have announced the first successful treatment for Huntington’s disease, a devastating inherited condition that ...

Eikonizo Therapeutics, a biopharmaceutical company developing disease-modifying therapies to improve the lives of people impacted by neurodegenerative and cardiorenal diseases, today announced the ...

Scientists have identified around 400 species of free-living amoebae, but only six are known to cause disease in humans - including Naegleria fowleri and Acanthamoeba, both of which can infect the ...

New research published in the journal The Lancet eBioMedicine links trouble sleeping with faster brain aging. If you struggle ...

Scientists found stranded dolphins show brain changes and toxins linked to Alzheimer’s during harmful algal blooms.

An analysis of the brains of the stranded dolphins revealed changes to gene expression that are associated with Alzheimer's ...